• Couto, C.G. (1999) Clinical approach to bleeding dog or cat. Veterinary Medicine, May, 450459.
  • FDA Center for Veterinary Medicine (CVM) Guidance for Industry 104: Content and Format of Effectiveness and Target Animal Safety Technical Sections and Final Study Reports for Submission to the Division of Therapeutic Drugs for Non-Food Animals, July 2001.
  • Guidance for industry, Bioanalytical method validation, May 2001: US Department of Health and Human Service, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (CVM), 7500 Standish Place, Rockville, MD 20855, USA.
  • Heinrich, N.A., McKeever, P.J. & Eisenschenk, M.C. (2011) Adverse events in 50 cats with allergic dermatitis receiving ciclosporin. Veterinary Dermatology, 22, 511520.
  • King, S., Favrot, C., Messinger, L., Nuttall, T., Steffan, J., Forster, S. & Seewald, W. (2012) A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis. Veterinary Dermatology, 23, 440e84.
  • McAnulty, J.F. & Lensmeyer, G.L. (1999) The effects of ketoconazole on the pharmacokinetics of cyclosporine A in cats. Veterinary Surgery, 28, 448455.
  • Mehl, M.L., Kyles, A.E., Craigmill, A.L., Epstein, S. & Gregory, C.R. (2003) Disposition of cyclosporine after intravenous and multi-dose oral administration in cats. Journal of Veterinary Pharmacology and Therapeutics, 26, 349354.
  • Mueller, E.A., Kovarik, J.M., van Bree, J.B., Tetzloff, W., Grevel, J. & Kutz, K. (1994) Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharmaceutical Research, 11, 301304.
  • de las Mulas, J.M., Millan, Y., Bautista, M.J., Perez, J. & Carrasco, L. (2000) Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Research in Veterinary Science, 68, 1521.
  • Noli, C. & Scarampella, F. (2006) Prospective open pilot study on the use of ciclosporin for feline allergic skin disease. Journal of Small Animal Practice, 47, 434438.
  • Palmeiro, B.S. (2013) Cyclosporine in Veterinary Dermatology. The Veterinary Clinics of North America. Small Animal Practice, 43, 153171.
  • Public Health Service Policy on Humane Care and Use of Laboratory Animals (1986) National Institutes of Health (US) Office of Protection from Research Risks.
  • Robson, D. (2003a) Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats. Veterinary Record, 152, 739748.
  • Robson, D. (2003b) Review of the properties and mechanisms of action of cyclosporine with an emphasis on dermatological therapy in dogs, cats and people. Veterinary Record, 152, 768772.
  • Ryffel, B. (1982) Experimental toxicological studies with cyclosporin A. In Cyclosporin A. Ed. White, D.J.G., pp 4575. Elsevier Biomedical Press, Amsterdam.
  • Swiss Ordinance relating to Good Laboratory Practice, adopted May 18, 2005 [RS 813.112.1] and based on The OECD Principles of Good Laboratory Practice, as revised in 1997 and adopted on November 26, 1997 by decision of the OECD Council C (97) 186/Final.
  • Tanaka, C., Kawai, R. & Rowland, M. (2000) Dose-dependent pharmacokinetics of cyclosporine A in rats: events in tissues. Drug Metabolism Disposition, 28, 582589.
  • Tanner, J.E. & Alfieri, C. (2001) The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transplant Infectious Disease, 3, 6069.
  • Target Animal Safety Guidelines for New Animal Drugs, Center for Veterinary Medicine (CVM), Food and Drug Administration, June 1989, and U.S. Food and Drug Administration (CVM Guideline 33).
  • United States Department of Agriculture (2009). Title 9 Code of Federal Regulations. Animal Welfare 7 U.S.C. 2131-2159; 7 CFR 2.22, 2.80, and 371.7
  • Vaden, S.L. (1997) Cyclosporine and tacrolimus. Seminars in Veterinary Medicine and Surgery (Small Animal), 12, 161166.
  • Vercelli, A., Raviri, G. & Cornegliani, L. (2006) The use of oral cyclosporin to treat feline dermatoses: a retrospective analysis of 23 cases. Veterinary Dermatology, 17, 201206.
  • Whalen, R.D., Tata, P.N., Burckart, G.J. & Venkataramanan, R. (1999) Species differences in the hepatic and intestinal metabolism of cyclosporine. Xenobiotica, 29, 39.
  • Wisselink, M.A. & Willemse, T. (2009) The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study. The Veterinary Journal, 180, 5559.